RJT
HALO icon

Raymond James Trust’s Halozyme HALO Stock Holding History

Raymond James Trust’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$266K Sell
4,649
-40
-0.9% -$2.29K 0.01% 1102
2024
Q2 		$246K Buy
+4,689
New +$206K 0.01% 1083

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Raymond James Trust's HALO Position: Q3 2024 in Review

Raymond James Trust reduced its Halozyme (HALO) stake by 0.85% in Q3 2024, selling an estimated $2.29K and leaving 4,649 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1102.

Raymond James Trust first reported a position in HALO in Q2 2024 and has held it in 2 quarters since. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • Raymond James Trust held 4,649 shares of Halozyme worth $266K as of Q3 2024.
  • Raymond James Trust sold 40 Halozyme shares in Q3 2024, an estimated $2.29K.
  • Halozyme made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #1102 holding.
  • Raymond James Trust first reported a position in Halozyme in Q2 2024 and has held it in 2 quarters since.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.